Showing results (1091-1100 of 2,331) with videos related to

Sort By:
Pageof 234
Clinical Drug Investigation|August 13, 2022
Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly SubjectsRamakrishna Nirogi, Vijay Benade, Vinod Kumar Goyal, et al.
Clinical Drug Investigation|March 8, 2023
Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price?Aurora Gonzalez-Fierro, Adriana Romo-Pérez, Alma Chávez-Blanco, et al.
Clinical Drug Investigation|February 25, 2025
The Cost Effectiveness of Adjunctive Medical Cannabis Therapy in the Treatment of Moderate Post-Traumatic Stress DisorderMitchell L Doucette, Dipak Hemraj, D Luke Macfarlan, et al.
Clinical Drug Investigation|January 28, 2025
Assessment of Reperfusion Efficacy of Altelyse Versus Actilyse in Patients with Acute Myocardial Infarction: A Phase 3, Randomized, Double-Blinded, Non-inferiority Clinical TrialMohammad Reza Beyranvand, Mohammad Asadpour Piranfar, Masoud Solaymani-Dodaran, et al.
Clinical Drug Investigation|November 14, 2024
A Single-Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use DisorderCeline M Laffont, Olga Lapeyra, Dipti Mangal, et al.
Clinical Drug Investigation|November 3, 2024
Pharmacokinetic Properties of a Once-Weekly Fixed-Ratio Combination of Insulin Icodec and Semaglutide Compared with Separate Administration of Each Component in Individuals with Type 2 Diabetes MellitusLisbet Westergaard, Lene Alifrangis, Stephen T Buckley, et al.
Clinical Drug Investigation|March 13, 2025
Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of the Novel HIF-PH Inhibitor Enarodustat: An Open-Label Phase I Study in Healthy Chinese ParticipantsCheng Cui, Xiaoye Niu, Haiyan Li, et al.
Clinical Drug Investigation|October 11, 2024
Neurological and Psychiatric Adverse Events Associated with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer Patients: Insights from a Pharmacovigilance Study via the FDA Adverse Event Reporting SystemZicheng Yu, Mengying Guan, Xiaolan Liao
Clinical Drug Investigation|October 14, 2024
Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report DatabaseToshiaki Sakamoto, Hirotaka Miyamoto, Junya Hashizume, et al.
Clinical Drug Investigation|September 6, 2024
The Effect of Placebo on Pruritus in Patients with Chronic Urticaria: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsPeiwen Xue, Haiyan Qin, Di Qin, et al.
Pageof 234